Fortis Capital Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Fortis Capital Advisors’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,400	Closed	-$37.7K	–	657
2023 Q1	$37.7K	Hold	31,400	–	–	0.02%	319
2022 Q4	$44.6K	Buy	+31,400	New	+$67.4K	0.03%	307

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fortis Capital Advisors's DBD Position: Q2 2023 in Review

Fortis Capital Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 31,400 shares — an estimated $37.7K sold.

Fortis Capital Advisors first reported a position in DBD in Q4 2022 and held it in 2 quarters. The position peaked at $44.6K in Q4 2022. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

Fortis Capital Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
Fortis Capital Advisors sold 31,400 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $37.7K.
Fortis Capital Advisors first reported a position in Diebold Nixdorf Incorporated in Q4 2022 and held it in 2 quarters.
Fortis Capital Advisors's Diebold Nixdorf Incorporated position peaked at $44.6K in Q4 2022.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Fortis Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.